TBPH Net Debt
Theravance Biopharma Inc · Net Debt
TBPH Net Debt
Latest reported-$92.31Mperiod ending
TBPH FY Net Debt ($69.00K → -$92.31M)
Annual net debt
High-resolution chart · PNG
TBPH net debt history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Debt (USD) |
|---|---|
| -92,308,000 | |
| 12,023,000 | |
| 9,614,000 | |
| -246,012,000 | |
| 579,559,000 | |
| 594,790,000 | |
| 452,464,000 | |
| 76,332,000 | |
| 134,766,000 | |
| -122,033,000 | |
| -112,707,000 | |
| -89,215,000 | |
| 0 | |
| 0 | |
| 69,000 |